Physician

Deborah R Wu, MD

According to 2025 Medicare claims, Deborah Wu, MD (NPI: 1760698245) practices ophthalmology in the Muskegon-Norton Shores, MI market, with the plurality of this provider's patient population coming from Muskegon, MI. This provider's primary affiliated billing organization is SHORELINE OPHTHALMOLOGY, PLLC (NPI: 1679643670; TIN: 38-3245641) and primary practice location at 49444-1837. Wu is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Wu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 361 traditional Medicare patients, billed 2,360 HCPCS/CPT codes, and received $135,757 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,137 prescription claims across 620 beneficiaries totaling $1,328,512 in drug costs, led by Oxervate (Cenegermin-Bkbj). 2018 DME data shows 11 claims. Open Payments data shows 21 records totaling $770. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $771,827 to $135,757. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $282,752 and ending at $1,328,512. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,507	7,736	$771,827
2016	1,418	7,561	$770,844
2017	1,190	6,960	$711,254
2018	1,156	8,540	$856,546
2019	984	8,171	$776,423
2020	554	4,067	$409,732
2021	333	1,660	$167,984
2022	352	2,234	$174,290
2023	350	2,223	$127,667
2024	361	2,360	$135,757

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	531	2,255	$282,752
2016	621	2,831	$345,663
2017	532	2,212	$305,874
2018	559	2,279	$356,123
2019	512	2,161	$607,642
2020	288	998	$539,371
2021	337	793	$227,528
2022	389	1,060	$170,958
2023	541	1,585	$724,944
2024	620	2,137	$1,328,512

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	71	71	$4,199
2016	133	133	$8,152
2017	N/R	N/R	N/R
2018	11	11	$627
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	255	321	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	128	198	$58
92083	Exam of visual field with extended testing	56	75	$39
92133	Imaging of optic nerve	72	88	$21
92285	Photography of content of eyes	79	83	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxervate	Cenegermin-Bkbj	20	280	$1,005,933
Restasis	Cyclosporine	158	8,400	$166,318
Lumigan	Bimatoprost	77	3,516	$26,395
Cyclosporine	Cyclosporine	55	3,405	$23,529
Combigan	Brimonidine Tartrate/Timolol	41	1,927	$12,528

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$770	BIOTISSUE HOLDINGS INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Deborah R. Wu, MD?

Tedicare shows public-source Medicare data for Deborah R. Wu, MD (NPI 1760698245), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Deborah R. Wu, MD have ACO affiliation data?

Deborah R. Wu, MD is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Deborah R. Wu, MD?

Deborah R. Wu, MD is linked to SHORELINE OPHTHALMOLOGY, PLLC (billing NPI 1679643670) in the available physician profile data.

Does Deborah R. Wu, MD have Open Payments data?

Deborah R. Wu, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.